Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cdc2-cyclin E complexes regulate the G1/S phase transition.

Eiman Aleem1, Hiroaki Kiyokawa, Philipp Kaldis

  • 1Mouse Cancer Genetics Program, National Cancer Institute, NCI-Frederick, Bldg 560/22-56, 1050 Boyles Street, Frederick, MD 21702-1201, USA.

Nature Cell Biology
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drosha Dice(r)ing lipid metabolism in the liver.

Cell chemical biology·2026
Same author

Global molecular landscape of early MASLD progression in human obesity.

eLife·2026
Same author

Cyclin-dependent kinase 10 controls bone formation and is linked to human skeletal health.

Journal of orthopaedic translation·2026
Same author

Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle.

Cancers·2026
Same author

Engineering an orthogonal ubiquitin transfer cascade with RING E3 RNF38 by phage display to reveal its regulation of nuclear transport.

The Journal of biological chemistry·2026
Same author

Can DNN models simulate appearance variations of #TheDress?

i-Perception·2025
Same journal

Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

Nature cell biology·2026
Same journal

An atlas of primate insular cortex reveals a signal-processing strategy in von Economo neurons.

Nature cell biology·2026
Same journal

Primate neurons with special signalling logic.

Nature cell biology·2026
Same journal

Cell surface liposome binding (CLiB) allows lipid-binding probe engineering via high-throughput screening.

Nature cell biology·2026
Same journal

Mapping the human female reproductive tract.

Nature cell biology·2026
Same journal

Learning from stem cell-based embryo models.

Nature cell biology·2026
See all related articles

The cyclin-dependent kinase inhibitor p27 (Kip1) normally suppresses tumors. However, in mice lacking both p27 and Cdk2, Cdc2 activity compensates, indicating parallel pathways in cell cycle regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The cyclin-dependent kinase inhibitor p27 (Kip1) is a known tumor suppressor and negative regulator of cell-cycle progression.
  • Cyclin-dependent kinase 2 (Cdk2) is a primary target of p27.
  • The genetic deletion of p27 in mice leads to specific phenotypes, and its interaction with Cdk2 is crucial for understanding cell cycle control.

Purpose of the Study:

  • To investigate the phenotypic consequences of combined p27 and Cdk2 deficiency in mice.
  • To determine if the loss of Cdk2 activity modifies the p27 knockout mouse phenotype.
  • To explore potential compensatory mechanisms in cell cycle regulation when Cdk2 function is lost.

Main Methods:

  • Generation and analysis of p27(-/-) Cdk2(-/-) double-knockout mice.

Related Experiment Videos

  • Tumorigenesis assessment in ovaries and pituitary glands.
  • Analysis of S phase and mitosis levels in mouse tissues.
  • Biochemical assays to measure Cdc2 activity and protein complex formation.

    • Main Results:

    • p27(-/-) Cdk2(-/-) mice developed ovary and pituitary tumors, but no functional complementation was observed, suggesting parallel pathways.
    • Elevated S phase and mitosis were detected in tissues of double-knockout mice.
    • Cdc2 activity was elevated in double-knockout mouse extracts, and p27 was found to bind to Cdc2 and cyclin complexes.
    • Cyclin E was observed to bind and activate Cdc2, suggesting a compensatory role.

    Conclusions:

    • The loss of Cdk2 function is not fully compensated by p27 deficiency alone, indicating parallel regulatory pathways.
    • Cdc2 activity can compensate for the loss of Cdk2 function in vivo.
    • These findings highlight the complex interplay of cell cycle regulators and suggest Cdc2 as a potential therapeutic target in cancers associated with p27 dysfunction.